Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Abstract Background This study investigated plasma biomarkers for neuroinflammation associated with Alzheimer’s disease (AD) in subjects with preclinical AD compared to healthy elderly. How these biomarkers behave in patients with AD, compared to healthy elderly is well known, but determining these...
Main Authors: | Samantha Prins, Marieke L. de Kam, Charlotte E. Teunissen, Geert Jan Groeneveld |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-022-01051-2 |
Similar Items
-
Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease
by: Julia Doroszkiewicz, et al.
Published: (2023-07-01) -
YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease
by: Ioannis Mavroudis, et al.
Published: (2021-12-01) -
Cerebrospinal fluid YKL‐40 level evolution is associated with autoimmune encephalitis remission
by: Guillaume Dorcet, et al.
Published: (2023-01-01) -
MCP-1 levels in astrocyte-derived exosomes are changed in preclinical stage of Alzheimer's disease
by: Ting Wang, et al.
Published: (2023-03-01) -
Astrocyte-specific knockout of YKL-40/Chi3l1 reduces Aβ burden and restores memory functions in 5xFAD mice
by: Xiaoyan Zeng, et al.
Published: (2023-12-01)